Pich, A <br/><br/>
Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 2000 
 - 2948-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2000.18.16.2948  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Antigens, Nuclear<br/>Biomarkers, Tumor<br/>Breast Neoplasms, Male--genetics<br/>Carcinoma, Ductal, Breast--genetics<br/>Chi-Square Distribution<br/>Gene Expression<br/>Genes, erbB-2--genetics<br/>Genes, p53--genetics<br/>Humans<br/>Immunohistochemistry<br/>Ki-67 Antigen<br/>Male<br/>Middle Aged<br/>Nuclear Proteins--analysis<br/>Prognosis<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>Proto-Oncogene Proteins c-myc--analysis<br/>Receptor, ErbB-2--analysis<br/>Receptors, Androgen--analysis<br/>Receptors, Estrogen--analysis<br/>Retrospective Studies<br/>Risk Factors<br/>Statistics, Nonparametric<br/>Survival Analysis<br/>Survival Rate<br/>Tumor Suppressor Protein p53--analysis